417 related articles for article (PubMed ID: 29571871)
41. Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
Mazzaschi G; Bordi P; Fioretzaki R; Gnetti L; Milanese G; Tommasi C; Bersanelli M; Roti G; Scoditti U; Leonardi F; Quaini F; Tiseo M
Clin Lung Cancer; 2020 Mar; 21(2):e65-e73. PubMed ID: 31837925
[No Abstract] [Full Text] [Related]
42. Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain.
Guiney TE; Lopes MS; Kalra MK; Mooradian MJ; Neilan TG; Stone JR
N Engl J Med; 2019 Sep; 381(13):1268-1277. PubMed ID: 31553841
[No Abstract] [Full Text] [Related]
43. Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.
Chauhan A; Burkeen G; Houranieh J; Arnold S; Anthony L
Ann Oncol; 2017 Aug; 28(8):2034-2038. PubMed ID: 28472223
[No Abstract] [Full Text] [Related]
44. Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma.
Shikano K; Kaneko K; Kaburaki K; Isobe K; Kawabe K; Homma S; Kawai S; Nanki T
Scand J Rheumatol; 2020 Jan; 49(1):82-83. PubMed ID: 31135242
[No Abstract] [Full Text] [Related]
45. Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.
Liu WK; Naban N; Kaul A; Patel N; Fusi A
Melanoma Res; 2021 Feb; 31(1):85-87. PubMed ID: 33196530
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
Abe K; Nakamura N; Isono A; Toyota H; Arai H; Saito K
Am J Gastroenterol; 2017 Nov; 112(11):1636. PubMed ID: 29109487
[No Abstract] [Full Text] [Related]
47. Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.
Miyauchi M; Toyoda M; Zhang J; Hamada N; Yamawaki T; Tanaka J; Harada K; Kashizaki F; Fukagawa M
J Diabetes Investig; 2020 May; 11(3):748-749. PubMed ID: 31587459
[TBL] [Abstract][Full Text] [Related]
48. [Effectiveness of a Low-dose Corticosteroid in a Patient with Polymyalgia Rheumatica Associated with Nivolumab Treatment].
Imai Y; Tanaka M; Fujii R; Uchitani K; Okazaki K
Yakugaku Zasshi; 2019; 139(3):491-495. PubMed ID: 30828027
[TBL] [Abstract][Full Text] [Related]
49. Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.
Arai T; Harada K; Usui Y; Irisawa R; Tsuboi R
J Dermatol; 2017 Aug; 44(8):975-976. PubMed ID: 27649838
[No Abstract] [Full Text] [Related]
50. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
[No Abstract] [Full Text] [Related]
51. Bilateral Anterior Uveitis Associated with Nivolumab Therapy.
Karlin J; Gentzler R; Golen J
Ocul Immunol Inflamm; 2018; 26(2):283-285. PubMed ID: 27599197
[No Abstract] [Full Text] [Related]
52. Linear IgA Disease of the Gingiva Following Nivolumab Therapy.
Jonna S; Neiders M; Lakshmanan S; Khan A; DeKlotz T; Lanasa D; Gibney GT; Liu SV
J Immunother; 2019; 42(9):345-347. PubMed ID: 31246639
[TBL] [Abstract][Full Text] [Related]
53. New onset of psoriasis during nivolumab treatment for lung cancer.
Chujo S; Asahina A; Itoh Y; Kobayashi K; Sueki H; Ishiji T; Umezawa Y; Nakagawa H
J Dermatol; 2018 Mar; 45(3):e55-e56. PubMed ID: 29205470
[No Abstract] [Full Text] [Related]
54. Nivolumab-induced aplastic anemia: A case report and literature review.
Comito RR; Badu LA; Forcello N
J Oncol Pharm Pract; 2019 Jan; 25(1):221-225. PubMed ID: 28825374
[TBL] [Abstract][Full Text] [Related]
55. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T
J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574
[No Abstract] [Full Text] [Related]
56. Anti-PD-1 Drug (Nivolumab) May Induce Acute and Life-Threatening Pancreatitis in Lung Cancer Patient: A Case Report.
Jiang R; Xu L; Huang Y; Fang C; Guo H; Li S; Wu J; Du Z
Pancreas; 2018 Sep; 47(8):e53-e54. PubMed ID: 30113432
[No Abstract] [Full Text] [Related]
57. Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast.
Fattore D; Annunziata MC; Panariello L; Marasca C; Fabbrocini G
Eur J Cancer; 2019 Mar; 110():107-109. PubMed ID: 30785013
[No Abstract] [Full Text] [Related]
58. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
59. Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC.
Kato R; Hayashi H; Sano K; Handa K; Kumode T; Ueda H; Okuno T; Kawakami H; Matsumura I; Kudo M; Nakagawa K
J Thorac Oncol; 2018 Dec; 13(12):e239-e241. PubMed ID: 30017828
[No Abstract] [Full Text] [Related]
60. Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.
Anastasopoulou A; Papaxoinis G; Diamantopoulos P; Christofidou E; Benopoulou O; Stratigos A; Gogas H
J Immunother; 2018 Apr; 41(3):164-167. PubMed ID: 29309291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
